Profiel
Mats Hellstrom was the founder of AngioGenetics AB, where he held the title of Chief Executive Officer from 2001 to 2009.
AngioGenetics AB was founded in 2001.
Dr. Hellstrom earned a doctorate degree from the University of Gothenburg in 2000.
Eerdere bekende functies van Mats Hellstrom
| Bedrijven | Functie | Einde |
|---|---|---|
AngioGenetics AB
 AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Oprichter | - |
Opleiding van Mats Hellstrom
| University of Gothenburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
AngioGenetics AB
AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Health Technology |
